Read More Pharma Industry News Could vimseltinib be the next big thing in TGCT treatment? FDA says Yes! The U.S. Food and Drug Administration (FDA) has granted priority review status to Deciphera Pharmaceuticals, Inc.’s New Drug… byPallavi MadhirajuAugust 16, 2024